V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220004295 | 220001745 | null | null | Disease modification (D) | null | 2014-10-17 | Hydroxycarbamide | N | N | 220025740 | HYDROXYCARBAMIDE |
| 220004296 | 220018638 | 1.62 | null | Curative (C) | 2016-08-07 | 2016-08-13 | Azacitidine | N | N | 220025748 | AZACITIDINE |
| 220004297 | 220018638 | 1.65 | 108 | Disease modification (D) | 2015-10-08 | 2015-10-23 | Azacitidine | 02 | N | 220025748 | AZACITIDINE |
| 220004298 | 220018638 | null | 84.8 | Palliative (P) | 2014-01-05 | 2014-02-09 | Azacitidine | N | N | 220025748 | AZACITIDINE |
| 220004299 | 220001746 | 1.62 | 78.8 | Palliative (P) | 2013-04-22 | 2013-04-22 | Azacitidine | N | N | 220025756 | AZACITIDINE |
| 220004300 | 220001746 | 1.6 | null | null | 2015-08-08 | 2015-08-08 | Azacitidine | 99 | null | 220025756 | AZACITIDINE |
| 220004301 | 220001747 | 1.78 | 72.7 | null | 2013-12-24 | 2014-01-02 | Azacitidine | 02 | N | 220025762 | AZACITIDINE |
| 220004302 | 220001747 | 1.7 | 71 | Palliative (P) | 2014-12-14 | 2014-12-14 | Azacitidine | N | null | 220025762 | AZACITIDINE |
| 220004303 | 220015781 | 0 | 71.2 | Palliative (P) | 2013-06-01 | 2013-06-01 | Hydroxycarbamide | 2 | N | 220025767 | HYDROXYCARBAMIDE |
| 220004304 | 220015781 | 0 | 0 | Palliative (P) | 2014-07-06 | 2014-07-07 | Hydroxycarbamide | N | N | 220025767 | HYDROXYCARBAMIDE |
| 220004305 | 220015781 | 1.72 | 56.3 | Curative (C) | 2016-10-25 | 2016-10-28 | Hydroxycarbamide | 02 | N | 220025767 | HYDROXYCARBAMIDE |
| 220004306 | 220015781 | null | 73.9 | Palliative (P) | 2016-04-14 | 2016-04-18 | Azacitidine | null | N | 220025767 | AZACITIDINE |
| 220004307 | 220015781 | null | null | Palliative (P) | 2014-07-04 | 2014-07-04 | Hydroxycarbamide | N | null | 220025767 | HYDROXYCARBAMIDE |
| 220004308 | 220015781 | 1.77 | null | Not known (9) | 2015-01-19 | 2015-01-19 | Azacitidine | 2 | null | 220025767 | AZACITIDINE |
| 220004309 | 220001748 | 1.72 | 65 | Disease modification (D) | 2014-12-29 | 2015-01-11 | Azacitidine | N | N | 220025786 | AZACITIDINE |
| 220004310 | 220001749 | null | -1 | Curative (C) | 2017-10-27 | 2017-10-27 | Azacitidine | 2 | null | 220025788 | AZACITIDINE |
| 220004311 | 220001749 | 0 | null | Disease modification (D) | 2015-06-14 | 2015-06-14 | Hydroxycarbamide | N | N | 220025788 | HYDROXYCARBAMIDE |
| 220004312 | 220001749 | 1.72 | 102.8 | null | 2015-01-20 | 2015-01-20 | Azacitidine | N | N | 220025788 | AZACITIDINE |
| 220004313 | 220001749 | 1.71 | 78 | Disease modification (D) | 2016-03-16 | 2016-03-17 | Azacitidine | 2 | N | 220025788 | AZACITIDINE |
| 220004314 | 220001750 | 1.68 | 123.1 | Palliative (P) | 2015-12-30 | 2016-01-14 | Azacitidine | 02 | Y | 220025792 | AZACITIDINE |
| 220004315 | 220010865 | null | 83.5 | Disease modification (D) | 2017-07-26 | 2017-08-08 | Azacitidine | 2 | N | 220025793 | AZACITIDINE |
| 220004316 | 220010865 | 1.8 | 90.6 | Curative (C) | 2017-10-07 | 2017-10-21 | Azacitidine | N | N | 220025793 | AZACITIDINE |
| 220004317 | 220010865 | 1.56 | 108 | Curative (C) | 2013-03-15 | 2013-03-15 | Azacitidine | 99 | N | 220025793 | AZACITIDINE |
| 220004318 | 220001751 | 0 | 78.6 | Curative (C) | 2013-02-13 | 2013-02-13 | AML17 TRIAL | Y | N | 220025799 | AML17 TRIAL |
| 220004319 | 220001751 | 1.69 | 59.6 | Curative (C) | 2017-11-16 | 2017-11-16 | AML17 TRIAL | 1 | N | 220025799 | AML17 TRIAL |
| 220004320 | 220001752 | 1.81 | 55 | Curative (C) | 2016-07-29 | 2016-07-29 | AML17 TRIAL | Y | N | 220025802 | AML17 TRIAL |
| 220004321 | 220010867 | null | null | null | 2017-11-09 | 2017-11-09 | Cytarabine low (10to20mg/m2) IV/SC | 2 | N | 220025803 | CYTARABINE |
| 220004322 | 220010867 | 1.71 | null | Curative (C) | 2014-11-17 | 2014-11-22 | AML17 TRIAL | N | N | 220025803 | AML17 TRIAL |
| 220004323 | 220010867 | null | 89 | Disease modification (D) | 2013-10-24 | 2013-10-25 | Trial Unspecified | Y | N | 220025803 | TRIAL |
| 220004324 | 220010867 | 1.7 | 71.8 | Curative (C) | 2015-10-11 | 2015-10-11 | LI-1 TRIAL | Y | null | 220025803 | TRIAL |
| 220004325 | 220010867 | 1.7 | 59.2 | Curative (C) | 2014-03-30 | 2014-03-30 | Trial Unspecified | Y | N | 220025803 | TRIAL |
| 220004326 | 220010867 | 1.75 | 97.1 | Not known (9) | 2014-10-11 | 2014-11-15 | Trial Unspecified | Y | N | 220025803 | TRIAL |
| 220004327 | 220010867 | 1.64 | 66.9 | Curative (C) | 2013-11-26 | 2013-11-26 | LI-1 TRIAL | 1 | N | 220025803 | TRIAL |
| 220004328 | 220010867 | null | 83.5 | Palliative (P) | 2015-07-27 | 2015-07-27 | Cytarabine Low Dose | 02 | N | 220025803 | CYTARABINE |
| 220004329 | 220010867 | 1.6 | null | Palliative (P) | 2016-03-02 | 2016-03-02 | Cytarabine Low Dose | N | N | 220025803 | CYTARABINE |
| 220004330 | 220001753 | null | 70.5 | Curative (C) | 2015-02-03 | 2015-02-06 | Trial Unspecified | 01 | null | 220025825 | TRIAL |
| 220004331 | 220001754 | 1.62 | 79.25 | Curative (C) | 2017-10-29 | 2017-11-03 | Trial Unspecified | N | N | 220025827 | TRIAL |
| 220004332 | 220001754 | 1.8 | 78 | Curative (C) | 2013-10-25 | 2013-10-25 | AML17 TRIAL | Y | N | 220025827 | AML17 TRIAL |
| 220004333 | 220001754 | 1.86 | null | Curative (C) | null | 2018-01-08 | Cytarabine Low Dose | N | null | 220025827 | CYTARABINE |
| 220004334 | 220001754 | 0 | 60.9 | Not known (9) | 2017-06-12 | 2017-06-12 | AML17 TRIAL | 1 | null | 220025827 | AML17 TRIAL |
| 220004335 | 220001755 | 1.5 | 85 | Curative (C) | 2014-02-25 | 2014-02-25 | AML17 TRIAL | 02 | N | 220025839 | AML17 TRIAL |
| 220004336 | 220001755 | 0 | 46 | Curative (C) | 2014-08-07 | 2014-08-07 | AML17 TRIAL | Y | N | 220025839 | AML17 TRIAL |
| 220004337 | 220015786 | null | 83 | null | null | 2013-08-26 | AML17 TRIAL | Y | null | 220025843 | AML17 TRIAL |
| 220004338 | 220015786 | 1.82 | 106.3 | Disease modification (D) | 2016-07-13 | 2016-07-13 | Trial Unspecified | Y | N | 220025843 | TRIAL |
| 220004339 | 220015786 | 1.77 | 79 | Curative (C) | 2014-05-13 | 2014-05-14 | Trial Unspecified | Y | N | 220025843 | TRIAL |
| 220004340 | 220001756 | 1.54 | 53.3 | Palliative (P) | 2017-12-28 | 2017-12-29 | Cytarabine Low Dose | 2 | N | 220025847 | CYTARABINE |
| 220004341 | 220001756 | 1.87 | null | Curative (C) | 2013-12-22 | 2013-12-22 | AML17 TRIAL | 1 | N | 220025847 | AML17 TRIAL |
| 220004342 | 220001756 | 1.81 | 79.8 | null | 2015-04-24 | 2015-04-29 | AML17 TRIAL | Y | N | 220025847 | AML17 TRIAL |
| 220004343 | 220001756 | null | 84.8 | Palliative (P) | 2013-03-09 | 2013-03-24 | Trial Unspecified | Y | N | 220025847 | TRIAL |
| 220004344 | 220001756 | 1.46 | 74.6 | Palliative (P) | 2015-11-08 | 2015-11-08 | Trial Unspecified | 01 | null | 220025847 | TRIAL |